This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 2008-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2009
Title: Miki Hiraoka: Innovator in Pulmonary Research
Introduction
Miki Hiraoka is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pulmonary research, particularly in the area of phospholipid catabolism. With a total of 2 patents, her work focuses on improving the understanding and treatment of pulmonary disorders.
Latest Patents
Hiraoka's latest patents include innovative methods and compositions for using alveolar macrophage phospholipase A2. The first patent is directed to methods and compositions for improving pulmonary surfactant catabolism. More specifically, it describes methods and compositions for making and using a lysosomal phospholipase A2 in the diagnosis and treatment of disorders such as pulmonary alveolar proteinosis. The second patent reiterates similar themes, emphasizing the importance of lysosomal phospholipase A2 in addressing phospholipid catabolism disorders.
Career Highlights
Miki Hiraoka is affiliated with the University of Michigan, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating serious pulmonary conditions.
Collaborations
Hiraoka collaborates with esteemed colleagues, including James A Shayman and Akira Abe, to advance her research initiatives.
Conclusion
Miki Hiraoka's innovative work in pulmonary research highlights her dedication to improving health outcomes through scientific advancements. Her contributions are paving the way for new diagnostic and treatment methods in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile